New data from French public health authorities reveals geographic disparities in the incidence and mortality of motor neuron diseases across France. While overall rates remained stable between 2010 and 2021, certain regions – including Brittany, Occitanie, and Auvergne – appear to be more significantly affected by these severe conditions. Understanding these regional differences is crucial for optimizing care and resource allocation for patients with these devastating illnesses.
Understanding Motor Neuron Diseases
Motor neuron diseases, with amyotrophic lateral sclerosis (ALS), also known as Charcot’s disease, accounting for nearly 90% of adult cases, are rare but very serious neurological conditions. They are characterized by progressive muscle paralysis, often leading to death within two to five years of diagnosis. Currently, there is no cure for these complex and poorly understood diseases.
French public health agency, Santé publique France (SpF), recently updated its data for the period 2010-2021, covering the entire country excluding Mayotte. The results indicate stable incidence and mortality rates over the decade. Approximately 2,500 new cases are diagnosed annually in France, and 1,840 patients die each year. This corresponds to an incidence of 3 to 3.5 cases per 100,000 inhabitants per year, a figure comparable to European averages. These diseases primarily affect people aged 70 to 79, and men are statistically more often affected.
Geographic Areas More Affected
SpF’s analysis reveals significant regional variations. Incidence, for example, ranges from 1.06 cases per 100,000 inhabitants in French Guiana to 3.77 cases in Brittany. Beyond regional averages, the study identifies specific areas more affected at a finer scale, such as intercommunal public establishments (EPCI).
Three main areas showed a higher incidence than expected between 2010 and 2021:
- Around Nîmes, Avignon and Alès: 557 cases observed compared to 449 expected.
- The sector of Guingamp and Lorient: 520 cases observed compared to 417 expected.
- The Clermont-Ferrand region: 315 cases observed compared to 241 expected.
Regarding mortality, two areas of excess mortality were identified:
- The area around Lorient and Vannes: 463 deaths observed compared to 334 expected.
- The Saint-Étienne area: 339 deaths observed compared to 298 expected.
What Explains These Disparities?
The reasons for these territorial variations remain unknown. Experts at Santé publique France rule out the possibility of better diagnostic performance or more comprehensive reporting in these regions.
We used the databases of the Health Insurance to identify people treated, hospitalized… Motor neuron diseases are very serious pathologies and we rarely miss them, so we probably have a good exhaustiveness of the cases there.
This was stated by Laurence Guldner, head of the Trauma and Aging unit at Santé publique France, as reported by Le Figaro.
The role of the environment is a potential avenue for investigation. The causes of motor neuron diseases are poorly understood, but it is estimated that about 10% of cases have a genetic origin, although this figure may be underestimated. For the remainder, an interaction between a genetic predisposition and environmental factors is strongly suspected.
Among the environmental factors studied as potential risks are:
- Exposure to certain heavy metals.
- Tobacco consumption.
- A history of traumatic brain injuries.
- Consumption of foods containing certain toxins.
- Certain occupations, such as agricultural or military work.
- Clusters of cases have also been observed in specific athletes, without a common cause being established.
Implications for Caregivers and Support Organizations
For caregivers and associations working with people affected by motor neuron diseases, this data highlights several points. First, the complexity of these conditions and the demand to continue research to understand their causes and develop treatments. Second, identifying more affected areas could ultimately refine the provision of care and support in these territories, adapting resources to the specific needs of the local population. A better understanding of risk factors, even if still limited, can also inform prevention and awareness, although action remains limited in the absence of preventive treatments. Continued epidemiological analysis is essential to inform strategies for patient care and support.
